Final Call: BAC, AAPL and more
The final call of the day with the ‘Options Action’ traders.
Similar Posts
Ultragenyx CEO talks the company’s path to profitability in developing drugs for rare diseases
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Dr. Emil Kakkis, Ultragenyx founder & CEO, joins ‘Closing Bell Overtime’ to talk drug trials and development, its path to profitability and more.
CNBC PRO Talks: Morningstar’s chief U.S. strategist on stocks to beat the volatility
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Dave Sekera, chief U.S market strategist for Morningstar, joined CNBC’s Julianna Tatelbaum on Wednesday for a frank conversation on the market outlook. 33:50 Wed, Jul 13 20229:16 AM EDT
Cramer’s Mad Dash: Chewy
CNBC’s Jim Cramer delivers his daily Mad Dash.
Cramer Remix: A better alternative to your 401(k)
Jim Cramer breaks down his methods on how to take more control of your retirement savings.
Pivoting to ‘Green New Deal’ investments will be tough for Berkshire: Analyst
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Catherine Seifert of CFRA discusses the likelihood of Berkshire Hathaway pivoting to ‘Green New Deal’ investments under a Biden presidency. 02:02 Sun, Nov 8 202010:50 PM EST
Options Action: Traders feeling bullish toward Lucid
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Mike Khouw, Optimize Advisors president, joins CNBC’s Melissa Lee and the Options Action traders to talk Lucid. 01:08 Mon, Nov 13 20236:42 PM EST
